• 1
    Bunn PA Jr., Chan DC, Earle K, et al. Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer. Semin Oncol. 2002; 29: 8794.
  • 2
    Gridelli C, Maione P, Airoma G, Rossi A. Selective cyclooxygenase-2 inhibitors and non-small-cell lung cancer. Curr Med Chem. 2002; 9: 18511858.
  • 3
    Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000; 355: 479485.
  • 4
    Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. World Health Organization International histological classification of tumours, 3rd ed. New York: Springer Verlag, 1999.
  • 5
    Manegold C. Chemotherapy for advanced non-small cell lung cancer: standards. Lung Cancer. 2001; 34: S165S170.
  • 6
    Greco FA. Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer. Lung Cancer. 2001; 34: S53S56.
  • 7
    Mani S, Graham MA, Bregman DB, Ivy P, Chaney SG. Oxaliplatin: a review of evolving concepts. Cancer Invest. 2002; 20: 246263.
  • 8
    Monnet I, de Cremoux H, Soulie P, et al. Oxaliplatin plus vinorelbine in advanced non-small cell lung cancer: final results of a multicenter Phase II study. Ann Oncol. 2002; 13: 103107.
  • 9
    Xu XC. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs. 2002; 13: 127137.
  • 10
    Dohadwala M, Luo J, Zhu L, et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem. 2001; 276: 2080920812.
  • 11
    Pyo H, Choy H, Amorino GP, et al. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res. 2001; 7: 29983005.
  • 12
    Moos PJ, Fitzpatrick FA. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci U S A. 1998; 95: 38963901.
  • 13
    Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. J Biol Chem. 2000; 275: 1483814845.
  • 14
    Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandin E synthetase. Prostaglandin Other Lipid Mediat. 2002; 68/69: 383399.
  • 15
    Kamei D, Murakami M, Nakatani Y, Ishikawa Y, Ishii T, Kudo I. Potential role of microsomal prostaglandin E synthetase-1 in tumorigenesis. J Biol Chem. 2003; 278: 1939619405.
  • 16
    Mattern J, Koomagi R, Volm M. Expression of drug resistance gene products during progression of lung carcinomas. Oncol Rep. 2002; 9: 11811184.
  • 17
    Bai F, Nakanishi Y, Kawasaki M, et al. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with non-small cell lung carcinoma. Cancer. 1996; 78: 416421.
  • 18
    Arai T, Yasuda Y, Takaya T, et al. Immunohistochemical expression of glutathione S-transferase-pi in untreated primary non-small cell lung cancer. Cancer Detect Prev. 2000; 24: 252257.
  • 19
    Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of an Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 1993; 53: 14751479.
  • 20
    Harada T, Ogura S, Yamazaki K, et al. Predictive value of expression of p53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers. Cancer Sci. 2003; 94: 394399.
  • 21
    Levin VA, Uhm JH, Jaeckle KA, et al. Phase III randomized study of post-radiotherapy chemotherapy with a-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clin Cancer Res. 2000; 6: 38783884.
  • 22
    Trussardi A, Poitevin G, Gorisse MC, et al. Sequential overexpression of LRP and MRP but not P-gp170 in VP-selected A549 adenocarcinoma cells. Int J Oncol. 1998; 13: 543548.
  • 23
    Thoren S, Jakobsson PJ. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthetase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur J Biochem. 2000; 267: 64286434.
  • 24
    Branle F, Lefranc F, Camby I, et al. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer. 2002; 95: 641655.
  • 25
    Nagy N, Legendre H, Engels O, et al. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer. 2003; 97: 18491858.
  • 26
    Hoffman RM. Metastatic orthotopic mouse models of lung cancer. Methods Mol Med. 2003; 74: 457464.
  • 27
    Hammond WG, Teplitz RL, Benfield JR. Lung cancer model for study of the metastatic process. Ann Thorac Surg. 1991; 52: 732736.
  • 28
    Hammond WG, Benfield JR, Teplitz RL. Metastases from fresh human non-small cell lung cancers propagated in nude mice. Cancer Lett. 1991; 61: 5360.
  • 29
    Johnson JR, Hammond WG, Benfield JR, Tesluk H. Successful xenotransplantation of human lung cancer correlates with the metastatic phenotype. Ann Thorac Surg. 1995; 60: 3236.
  • 30
    Volm M, Mattern J, Koomagi R. Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance. Anticancer Drugs. 1997; 8: 931936.
  • 31
    Nagamachi Y, Tani M, Shimizu K, Tsuda H, Niitsu Y, Yokota J. Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice. Cancer Lett. 1998; 127: 203209.
  • 32
    Kraus-Berthier L, Jan M, Guilbaud N, Naze M, Pierre A, Atassi G. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice. Clin Cancer Res. 2000; 6: 297304.
  • 33
    Yamaura T, Murakami K, Doki Y, et al. Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer. Neoplasia. 2000; 2: 315324.
  • 34
    Wang X, Fu X, Hoffman RM. A patient-like metastasizing model of human lung adenocarcinoma constructed via thoracotomy in nude mice. Anticancer Res. 1992; 12: 13991401.
  • 35
    Hastings RH, Burton DW, Summers-Torres D, Quintana R, Biederman E, Deftos LJ. Splenic, thymic, lung and lymph node metastases from orthotopic human lung carcinomas in immunocompromised mice. Anticancer Res. 2000; 20: 36253629.
  • 36
    Ramesh R, Saeki T, Templeton NS, et al. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther. 2001; 3: 337350.
  • 37
    Ji L, Nishizaki M, Gao B, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 2002; 62: 27152720.
  • 38
    Sato J, Sata M, Nakamura H, et al. Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma. Int J Cancer. 2003; 106: 863870.
  • 39
    Mase K, Iijima T, Nakamura N, et al. Intrabronchial orthotopic propagation of human lung adenocarcinoma. Characterizations of tumorigenicity, invasion and metastasis. Lung Cancer. 2002; 36: 271276.
  • 40
    Yoshimatsu K, Altorki NK, Golijanin D, et al. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res. 2001; 7: 26692674.
  • 41
    Volm M, Mattern J, Samsel B. Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors. Cancer. 1992; 70: 764769.
  • 42
    Ha HC, Woster PM, Yager JD, Casero RA Jr. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci U S A. 1997; 94: 1155711562.
  • 43
    Carlisle DL, Devereux WL, Hacker A, Woster PM, Casero RA Jr. Growth status significantly affects the response of human lung cancer cells to antitumor polyamine-analogue exposure. Clin Cancer Res. 2002; 8: 2684269.
  • 44
    Farinelle S, DeDecker R, Malonne H, Werry J, Darro F, Kiss R. Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinoma. Anticancer Res. 1999; 19: 11711180.